L. Hanssens
About
In The Last Decade
L. Hanssens
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 111
- Psychiatry and Mental health 294
- Pulmonary and Respiratory Medicine 291
- Physiology 249
- Immunology and Allergy 191
- Endocrinology, Diabetes and Metabolism 184
Countries citing papers authored by L. Hanssens
This map shows the geographic impact of L. Hanssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Hanssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Hanssens more than expected).
Fields of papers citing papers by L. Hanssens
This network shows the impact of papers produced by L. Hanssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Hanssens. The network helps show where L. Hanssens may publish in the future.
Co-authorship network of co-authors of L. Hanssens
This figure shows the co-authorship network connecting the top 25 collaborators of L. Hanssens. A scholar is included among the top collaborators of L. Hanssens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Hanssens. L. Hanssens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 19 | |
| 3 | 12 | |
| 4 | 4 | |
| 5 | 184 | |
| 6 | 44 | |
| 7 | 124 | |
| 8 | 35 | |
| 9 | Screening for diabetes and other metabolic abnormalities in patients with schizophrenia and schizoaffective disorder: Evaluation of incidence and screening | 1 |
| 10 | P353 - Anomalies de la tolérance au glucose chez les patients schizophrènes traités par antipsychotiques de seconde génération : étude comparative prospective de 3 mois | 2 |
| 11 | Prevalence and incidence rates of metabolic abnormalities and diabetes in a prospective study of patients treated with second-generation antipsychotics | 14 |
| 12 | 83 | |
| 13 | Statin therapy among schizophrenia patients with dyslipidemia | 1 |
| 14 | L'allergie alimentaire chez l'enfant: étude d'une cohorte belge. | 0 |
| 15 | Oral glucose tolerance tests in schizophrenia for "dummies," making sense of potentially predictive prediabetic insulin and glucose curves | 2 |
| 16 | Metabolic syndrome in schizophrenic patients treated with antipsychotics | 1 |
| 17 | 4 | |
| 18 | The metabolic syndrome in schizophrenic patients treated with antipsychotics | 1 |
| 19 | Oral glucose tolerance tests in schizophrenic patients treated with antipsychotics | 1 |
| 20 | Evaluation of the osteoporosis self-assessment tool (OST) as a screening test for osteoporosis and osteopenia in men | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.